Oakley R H, Sar M, Cidlowski J A
Laboratory of Integrative Biology , National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 1996 Apr 19;271(16):9550-9. doi: 10.1074/jbc.271.16.9550.
Alternative splicing of the human glucocorticoid receptor (hGR) primary transcript produces two receptor isoforms, hGRalpha and hGRbeta, which differ at their carboxyl termini. The hGRalpha isoform conveys endocrine information to target tissues by altering patterns of gene expression in a hormone-dependent fashion. In contrast to hGRalpha, very little is known about the hGRbeta splice variant. Using hGRalpha- and hGRbeta-specific riboprobes on human multiple tissue Northern blots, we show that the hGRbeta message has a widespread tissue distribution. We also prove by reverse transcriptase-polymerase chain reaction that the alternative splicing event underlying the formation of the hGRbeta message occurs in these tissues. Because the hGRbeta protein differs from hGRalpha at the extreme COOH terminus, we investigated several of the biochemical properties of hGRbeta expressed in transfected cells. hGRbeta does not bind the glucocorticoid agonist dexamethasone nor the glucocorticoid antagonist RU38486 in vivo. Moreover, in contrast to hGRalpha, hGRbeta is located primarily in the nucleus of transfected cells independent of hormone administration. Finally, in the absence of hGRalpha, hGRbeta is transcriptionally inactive on a glucocorticoid-responsive enhancer. However, when both isoforms are expressed in the same cell, hGRbeta inhibits the hormone-induced, hGRalpha-mediated stimulation of gene expression. Thus, hGRbeta potentially functions as a dominant negative inhibitor of hGRalpha activity.
人类糖皮质激素受体(hGR)初级转录本的可变剪接产生了两种受体亚型,即hGRα和hGRβ,它们的羧基末端有所不同。hGRα亚型通过以激素依赖的方式改变基因表达模式,将内分泌信息传递给靶组织。与hGRα不同,人们对hGRβ剪接变体了解甚少。我们在人类多组织Northern印迹上使用hGRα和hGRβ特异性核糖探针,发现hGRβ的信使核糖核酸(mRNA)具有广泛的组织分布。我们还通过逆转录聚合酶链反应证明,hGRβ信使核糖核酸形成背后的可变剪接事件发生在这些组织中。由于hGRβ蛋白在极端COOH末端与hGRα不同,我们研究了转染细胞中表达的hGRβ的几种生化特性。hGRβ在体内既不结合糖皮质激素激动剂地塞米松,也不结合糖皮质激素拮抗剂RU38486。此外,与hGRα不同,hGRβ主要位于转染细胞的细胞核中,与激素给药无关。最后,在没有hGRα的情况下,hGRβ对糖皮质激素反应性增强子转录无活性。然而,当两种亚型在同一细胞中表达时,hGRβ会抑制激素诱导的、hGRα介导的基因表达刺激。因此,hGRβ可能作为hGRα活性的显性负抑制剂发挥作用。